Sriram Ryali bought $25k of CRBU
Chief Financial Officer at Caribou Biosciences, Inc.. 17,360 shares at an average of $1.42, traded Jan 29, 2025, filed Jan 30, 2025.
Score components
- +22RoleCFO
- 0Trade size$25k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -10.7%, 3m -38.8%, 6m +55.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001762893-25-000009, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jan 29, 2025 | POpen-market purchase Common Stock | +17,360 | $1.42 | $25k | 17,360 | Jan 30, 2025 |
Related signals
Other insiders at Caribou Biosciences, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 30Weak | Caribou Biosciences, Inc. | Timothy P Kelly Chief Technology Officer | $12k 6,228 shares | -8% | |
| 10Weak | Caribou Biosciences, Inc. | Tina M. Albertson Chief Medical Officer | $2,089 1,066 shares | -2% | |
| 10Weak | Caribou Biosciences, Inc. | Barbara G McClung Chief Legal Officer | $14k 6,938 shares | -1% | |
| 30Weak | Caribou Biosciences, Inc. | Timothy P Kelly Chief Technology Officer | $6,168 3,147 shares | -4% | |
| 10Weak | Caribou Biosciences, Inc. | Ruhi Ahmad Khan Chief Business Officer | $14k 6,938 shares | -6% | |
| 20Weak | CRBUbuy Caribou Biosciences, Inc. | Rachel E. Haurwitz President and CEO | $20k 20,000 shares | +1% | |
| 10Weak | Caribou Biosciences, Inc. | Barbara G McClung Chief Legal Officer | $4,811 3,564 shares | -1% | |
| 10Weak | Caribou Biosciences, Inc. | Steven Kanner Chief Scientific Officer | $4,811 3,564 shares | -1% | |
| 10Weak | Caribou Biosciences, Inc. | Ruhi Ahmad Khan Chief Business Officer | $4,811 3,564 shares | -5% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.